Related Experiment Video
Updated: Nov 9, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus
Adriana Perez1, Amanda Cantor2, Bryan Rudolph1
1Division of Gastroenterology, Hepatology and Nutrition, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.
Insights
Elevated liver enzymes (E-ALT) in children with SARS-CoV-2 infection indicate more severe disease, particularly in multisystem inflammatory syndrome (MIS-C). E-ALT was more common in MIS-C than COVID-19 but not linked to mortality.
Area of Science:
- Pediatric Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection can cause acute liver injury (ALI), associated with poor outcomes in adults.
- Understanding SARS-CoV-2 related liver injury in children is crucial for managing different disease manifestations.
Purpose of the Study:
- To compare the characteristics of children with elevated alanine aminotransferase (E-ALT) in two SARS-CoV-2 manifestations: multisystem inflammatory syndrome in children (MIS-C) and COVID-19.
- To identify factors associated with E-ALT in pediatric COVID-19 and MIS-C cases.
Main Methods:
- Retrospective study of 291 patients ≤21 years old with SARS-CoV-2 PCR positivity.
- E-ALT defined as ALT > 40 U/L. Bivariate and multivariable logistic regression analyses were performed.
- Comparison of E-ALT prevalence and associated factors between COVID-19 and MIS-C cohorts.
Main Results:
- 36% of patients had E-ALT (31% with COVID-19, 51% with MIS-C).
- In COVID-19, E-ALT associated with obesity, immunocompromise, and higher C-reactive protein.
- In MIS-C, E-ALT associated with male gender and Black race. Children with E-ALT in both groups had more severe disease, longer hospitalizations, and ICU stays. MIS-C carried a 2.3-fold increased risk of E-ALT compared to COVID-19.
Conclusions:
- Elevated liver enzymes in SARS-CoV-2 infected children present as transaminitis without hepatic synthetic dysfunction.
- Children with E-ALT, regardless of COVID-19 or MIS-C, experienced more severe clinical outcomes.
- MIS-C demonstrated a higher prevalence of E-ALT compared to COVID-19 in pediatric patients.
Background And Aims:
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) associated acute liver injury (ALI) has been linked to poor outcomes in adults. Here we compare characteristics in children with elevated ALT (E-ALT) in two distinct manifestations of the infection, multisystem inflammatory syndrome-children (MIS-C) and coronavirus disease 2019 (COVID-19).
Methods:
This is a retrospective study of patients ≤21 years of age with positive for SARS-CoV-2 PCR. E-ALT was defined as alanine aminotransferase (ALT) > 40 U/L. Bivariate analysis and multivariable logistic regression were obtained to describe differences in children with and without E-ALT in COVID-19 and MIS-C.
Results:
E-ALT was detected in 36% of the 291 patients; 31% with COVID-19, and 51% with MIS-C. E-ALT in COVID-19 was associated with obesity (P < .001), immunocompromised status (P = .04), and chronic liver disease (P = .01). In the regression models, E-ALT in COVID-19 was associated with higher c-reactive protein (OR 1.08, P = .01) after adjusting for common independent predictors. Children with E-ALT and MIS-C were more often boys (P = .001), Hispanic (P = .04), or Black (P < .001). In MIS-C, male gender (OR 5.3, P = .02) and Black race (OR 4.4, P = .04) were associated with increased odds of E-ALT. Children with E-ALT in both cohorts had significantly higher multiorgan dysfunction, longer hospitalization, and ICU stay. Children with MIS-C had 2.3-fold increased risk of E-ALT compared to COVID-19. No association was found between E-ALT and mortality.
Conclusion:
E-ALT with SARS-CoV-2 presents as elevated transaminases without hepatic synthetic dysfunction. Patients with either manifestation of SARS-CoV-2 infection and E-ALT experienced more severe disease.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Myocarditis II: Clinical Features and Diagnostic Tests
Viral Recombination
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...